Microbiome & Chronic Diseases

Evidence Based Medicine
Sign in
≡ List 

Disease ⇒ Depression ⇒ Severe Mental Disorders {40000114}

Record Keys



Initialisation date:
Other Terms:
Depressive Disorders, major depressive disorder, MDD


Meta Information

MedDra ID:[  ]
MedDra Level:[  ]
ICD:[  ]
Zone:[  ]
Mechanism:[  ]


[  ]

References Notes

[  ]

Shared Reference Notes

  • [1.2
    - One previously uncultured bacterium, provisionally named Evtepia gabavorous KLE1738, which required the presence of Bacteroides fragilis KLE1758 for growth. Using bio-assay driven purification of B. fragilis supernatant, Gama-aminobutyric acid (GABA), the major inhibitory neurotransmitter of the mammalian central nervous system, was identified as the growth factor of E. gabavorous. In vitro feeding experiments and genomic analysis of E. gabavorous suggests an unusual metabolism focused on consuming GABA.
    - Using growth of E. gabavorous as an indicator. Reduced levels of GABA are associated with depression, and we found fewer GABA producers in a human cohort of depressed, bipolar, and/or schizophrenic individuals. By modulating the level of GABA, microbial producers and consumers of this neurotransmitter may be influencing host.
  • [1.9
    - GABA is the growth factor produced by Bacteroides fragilis.
    - An inverse relationship between the relative abundance of fecal Bacteroidesand functional connectivity in a part of the brain associated with elevated activity during depression. This means that low abundance of Bacteroides was associated with high activity in that part of the brain, and vice versa.
  • [1.4
    - There is a decrease in the endocannabinoid (eCB) signaling due to lower peripheral levels of fatty acid precursors of eCB ligands.
    - The adverse effects of UCMS-transferred microbiota is alleviated by selectively enhancing the central eCB or by complementation with a strain of the Lactobacilli genus.
  • [1.10
    - Chemogenetic activation of striatal microglia induces an aversive affective state
    - Chemogenetic inhibition of microglia blocks inflammation-induced aversion
    - Microglial interleukin 6 signaling and prostaglandin synthesis regulate affective state
    - Prostaglandin E2 from activated microglia reduces the excitability of striatal neurons
  • [1.11
    - It is found that the transfer of the microbiota from models with depression to that of other animals deprived of their microbiota also determined the transfer of the behavioral and physiological characteristics of the depression
  • - The administration of a probiotic cocktail, composed of Lactobacillus rhamnosus and Lactobacillus helveticus, reduced the symptoms of depression and anxiety
  • - Butyrate reduced the depressive behavior, exerting an effect on the CNS in rats
  • [1.12
    - Combination of probiotics and polyphenol-rich prebiotics, a synbiotic >attenuates the chronic-stress induced inflammatory responses in the ileum and the prefrontal cortex promoting > resilience to the consequent depressive- and anxiety-like behaviors in male mice.
    - This effect may be attributed to specific synbiotic-produced metabolites including 4-hydroxyphenylpropionic, 4-hydroxyphenylacetic acid and caffeic acid > promoted anti-inflammatory activity through the aryl hydrocarbon receptor (AHR).
  • [1.6
    - Lactobacillus reuteri and Bifidobacterium adolescentis Probitica > reduction in depressive symptoms at four and eight weeks of treatment, and anxiety symptoms at four weeks.
    > improvement in sleep quality.
    - Lactobacillus reuteri and Bifidobacterium adolescentis Probitica > decrease in serum interleukin-6 levels.
    - Lactobacillus reuteri and Bifidobacterium adolescentis Probitica > increased Bifidobacteriaceae and Lactobacillacea, whereas it decreased Enterobacteriaceae in the gut microbiota composition.
  • [1.5
    - Morganella, was significantly increased in a microbial survey of the 181 people in the study who later developed depression.

  • [1.7
    - depression > glutamate and acetylcholine neurotransmitter levels are higher, while GABA neurotransmitter levels are lower.
    - regulation of the Kyn/tryptophan pathway may affect the receptors of NMDA in the CNS, might be involved in the progression of depression
  • [1.13
    - patients with depression were two times as likely to develop IBD.
    - 30% of inflammatory bowel disease (IBD) patients develop depression.
  • [1.14
    - kynurenine and indole derivatives might be associated with neurogenic depression
  • - reduced levels of SCFAs were observed in patients with Alzheimer's disease, and they also promoted depression-like behaviors and impairments of short-term memory in mice
  • - Oral gavages of Klebsiella oxytoca, Escherichia coli, and Cronobacter sakazakii belonging to Enterobacteriaceae, singly or together, caused dose-dependently colitis and depression-like behaviors in germ-free and specific-pathogen-free mice.
  • - Enterococcus faecium and Pediococcus acidolactici did not significantly cause colitis and depression-like behaviors, they significantly deteriorated Klebsiella oxytoca- or Escherichia coli-induced colitis, neuroinflammation, and anxiety/depression-like behaviors and increased blood LPS, corticosterone, and IL-6 levels.
  • [1.3
    - High proline consumption was the dietary factor with the strongest impact on depression.
    - Proline supplementation in mice exacerbated depression along with microbial translocation.
    - RNAi-mediated knockdown of proline and GABA transporters in Drosophila and mono-association with L. plantarum, a high GABA producer, conferred protection against depression-like states.
  • [1.15
    - Lactobacillus rhamnosus reduce stress-induced corticosterone and anxiety- and depression-related behavior.
  • [1.8
    - Researchers identified two bacterial genera " Coprococcus and Dialister " were depleted in patients with depression whether or not they were taking antidepressants.

Common References